Plain-English translation of NCT05284877 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is following organ transplant recipients over time to understand how often they get infections with HPV (a virus linked to certain cancers) and skin cancers. Because transplant recipients take medications to prevent their body from rejecting the new organ, their immune system is weakened, which may make them more vulnerable to these infections and cancers. Researchers will compare what happens in transplant recipients to what happens in people with normal immune systems.
Organ transplant recipients need to take immune-suppressing medications for life, which protects the transplanted organ but may increase cancer risk. By understanding how common HPV infections and skin cancers are in this population, and what factors make them more likely, doctors can better screen for and prevent these diseases.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will visit a dermatology clinic at one of three hospitals in Denmark. At your first visit, you will complete a questionnaire, have your skin examined by a doctor, and provide samples (a self-collected cervical swab and oral swab for women, and a blood sample). Women will repeat the cervical swab at 12 months. Some participants will also have vitamin D blood tests at baseline and 6 months. The study will follow you for at least one year to track whether you develop HPV infections or skin changes.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Denmark